Ma Daqing

Professor Daqing Ma holds the British Oxygen Company (BOC) Chair of Anaesthesia and serves as Head of Anaesthesia in Imperial College London's Department of Surgery and Cancer. He previously held roles such as Macintosh Professor (2014-2016) and has been recognized with awards including the Rex Ierlm Medal and Hall of Fame Award. His research focuses on noble gases' protective effects (xenon/argon) in critical care, organ transplantation, and oncology. Notably, his work established xenon's role in neonatal brain injury and adult cardiac arrest, influencing clinical trials and WADA doping regulations. Recent studies explore anaesthetics' impact on cancer behavior and postoperative cognitive decline in the elderly, leading to improved perioperative strategies. His H-index (58/Web of Science, 70/Google Scholar) reflects over 17,000 citations, underscoring his profound impact on surgical sciences.

Research Highlights:

• Pioneer of xenon/argon organoprotection mechanisms
• First to link anaesthetics to cancer cell malignancy via HIF-1α
• Leads investigations into postoperative cognitive decline and delirium prevention

Awards:

• 2013: FRCA Fellowship by Election
• 2014: Macintosh Professor & Rex Ierlm Medal
• 2015: Chinese Anaesthesiology Development Contribution Award
• 2018: International Academy of Anesthesiology Hall of Fame

Key Contributions: Translational research in xenon therapy, perioperative care optimization, and anaesthetic oncology effects. His work has directly influenced clinical practices in critical care, transplantation, and elderly surgical patient management.